Evidence map›Paper›PMID 37092235›Full record

Trial reportJournal of Parkinson's disease2023

Structural-Functional Correlates of Response to Pedunculopontine Stimulation in a Randomized Clinical Trial for Axial Symptoms of Parkinson's Disease.

Sorin Breit, Luka Milosevic, Georgios Naros, Idil Cebi, Daniel Weiss, Alireza Gharabaghi

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of Parkinson's disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 3 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sorin BreitDepartment for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, and German Centre of Neurodegenerative Diseases (DZNE), University Hospital and University Tübingen, Tübingen, Germany.
Luka MilosevicInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
Georgios NarosInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
Idil CebiDepartment for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, and German Centre of Neurodegenerative Diseases (DZNE), University Hospital and University Tübingen, Tübingen, Germany.
Daniel WeissDepartment for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, and German Centre of Neurodegenerative Diseases (DZNE), University Hospital and University Tübingen, Tübingen, Germany.
Alireza GharabaghiInstitute for Neuromodulation and Neurotechnology, University Hospital and University of Tübingen, Tübingen, Germany.
German Center for Neurodegenerative Diseases · DEUniversity of Tübingen · DEUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAxial symptoms of Parkinson's disease (PD) can be debilitating and are often refractory to conventional therapies such as dopamine replacement therapy and deep brain stimulation (DBS) of the subthalamic nuclei (STN).

objectiveEvaluate the efficacy of bilateral DBS of the pedunculopontine nucleus area (PPNa) and investigate structural and physiological correlates of clinical response.

methodsA randomized, double-blind, cross-over clinical trial was employed to evaluate the efficacy of bilateral PPNa-DBS on axial symptoms. Lead positions and neuronal activity were evaluated with respect to clinical response. Connectomic cortical activation profiles were generated based on the volumes of tissue activated.

resultsPPNa-DBS modestly improved (p = 0.057) axial symptoms in the medication-off condition, with greatest positive effects on gait symptoms (p = 0.027). Electrode placements towards the anterior commissure (ρ= 0.912; p = 0.011) or foramen caecum (ρ= 0.853; p = 0.031), near the 50% mark of the ponto-mesencephalic junction, yielded better therapeutic responses. Recording trajectories of patients with better therapeutic responses (i.e., more anterior electrode placements) had neurons with lower firing-rates (p = 0.003) and higher burst indexes (p = 0.007). Structural connectomic profiles implicated activation of fibers of the posterior parietal lobule which is involved in orienting behavior and locomotion.

conclusionBilateral PPNa-DBS influenced gait symptoms in patients with PD. Anatomical and physiological information may aid in localization of a favorable stimulation target.

Indexed as

Deep Brain StimulationParkinson DiseasePedunculopontine Tegmental NucleusSubthalamic NucleusGaitHumansDeep brain stimulationParkinson’s diseasepedunculopontine nucleus

Identifiers

PMID37092235
PMCPMC10357146
OpenAlexW4366264559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.